Survival Outcomes in Malignant Brain Tumors

Malignant brain tumours, notably glioblastoma, represent one of the most formidable challenges in oncology due to their diffuse growth, resistance to therapy and dismal prognosis. Median overall survival for high-grade gliomas remains under two years despite advances in neurosurgical techniques, radiotherapy and chemotherapeutic regimens. Prognosis is influenced by a constellation of factors including patient age, performance status, tumour molecular profile and extent of resection. Socioeconomic and demographic variables further modulate outcomes, reflecting disparities in access to specialised care and supportive services. Emerging approaches such as deep-learning models and precision medicine promise improved stratification of risk and tailored therapeutic pathways. A comprehensive understanding of these multifaceted determinants is essential to guide clinical decision-making, optimise resource allocation and inform global health strategies aimed at narrowing survival gaps.

Research from Nature Portfolio

Recent studies have harnessed large registry data to develop artificial-intelligence tools that predict individual survival trajectories in glioblastoma. A deep neural network trained on tens of thousands of cases achieved over 90 percent accuracy in classifying survival intervals and demonstrated robust regression performance, with age at diagnosis emerging as the predominant driver in model explanations. This tool offers clinicians an interpretable supplement to existing prognostic nomograms. In the paediatric setting, an analysis of childhood central nervous system tumours revealed pronounced racial and ethnic disparities in post-diagnosis survival. After adjustment for stage at presentation, minority groups, particularly Hispanic and Black children, exhibited higher mortality risk, implicating differential access to high-quality care as a key mediator of outcome inequities.

Survival Outcomes in Malignant Brain Tumors publication trend

The graph below shows the total number of articles in survival outcomes in malignant brain tumors across all publications each year (not limited to Nature Index journals).

Technical terms

Glioblastoma: An aggressive, high-grade primary brain tumour characterised by rapid growth and resistance to therapy.

Overall survival (OS): The length of time from diagnosis until death from any cause.

Shapley additive explanations (SHAP): A method to attribute the contribution of each input feature to the output of a machine-learning model.

Socioeconomic status (SES): A composite measure of an individual’s economic and social position based on income, education and occupation.

References

1. Survival prediction of glioblastoma patients using modern deep learning and machine learning techniques. Scientific Reports (2024).
2. Population-Based Analysis of Demographic and Socioeconomic Disparities in Pediatric CNS Cancer Survival in the United States. Scientific Reports (2020).
3. Demographic variation in incidence of adult glioma by subtype, United States, 1992-2007. BMC Cancer (2011).
4. Effect of marital status on survival in glioblastoma multiforme by demographics, education, economic factors, and insurance status. Cancer Medicine (2018).
5. Impact of race on care, readmissions, and survival for patients with glioblastoma: an analysis of the National Cancer Database. Neuro-Oncology Advances (2021).